Science Explorer Interactive view Map
Research facility · Paris · France

Optimisation Thérapeutique en Neuropsychopharmacologie

World rank, 2022–2025
#18,264
of 28,054 · #22,867 all time
Rank in France
#841
of 1,422
Research works
172
▲ 106% vs 2013–17
Citations
3.1k
17.9 per fractional work
Top-10% rate
17.8%
record average 16.5%
Open access
48%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.37× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.09× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 2.05× its world share, 1 worksImmunology and Micro…Neuroscience: 4.00× its world share, 4 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 13.48× its world share, 3 worksPharmacology, Toxico…Chemistry: 0.74× its world share, 1 worksChemistryComputer Science: 0.08× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.13× its world share, 0 worksEarth and Planetary …Engineering: 0.09× its world share, 1 worksEngineeringEnvironmental Science: 0.34× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.20× its world share, 0 worksMaterials ScienceMathematics: 0.14× its world share, 0 worksMathematicsDentistry: 0.21× its world share, 0 worksDentistryHealth Professions: 1.10× its world share, 2 worksHealth ProfessionsMedicine: 2.92× its world share, 37 worksMedicineNursing: 1.10× its world share, 0 worksNursingVeterinary: 5.29× its world share, 0 worksVeterinaryDecision Sciences: 0.16× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.07× its world share, 0 worksEconomics, Econometr…Psychology: 1.65× its world share, 3 worksPsychologySocial Sciences: 0.18× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 13.5×. Every wedge is a field page.

Which keywords describe research at Optimisation Thérapeutique en Neuropsychopharmacologie?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Neuroimaging, Oxidative Stress, Inflammation, Neurobiology, Genetics, Biomarkers, Neurodegeneration and Neuroinflammation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Oxidative Stress6▲ 5.2×23 topics
  2. Inflammation5▲ 3.9×37 topics
  3. Neuroimaging5▲ 27×8 topics
  4. Epidemiology4▲ 1.52×47 topics
  5. Neurobiology4▲ 20×9 topics
  6. Genetics3▲ 6.9×10 topics
  7. Biomarkers3▲ 6.6×12 topics
  8. Treatment3▲ 3.5×22 topics
  9. Cognitive Function3▲ 21×5 topics
  10. Neurodegeneration3▲ 13×9 topics
  11. Neuroinflammation3▲ 14×6 topics
  12. Prevalence2▲ 9.2×7 topics
  13. Aging2▲ 6.6×10 topics
  14. Diagnosis2▲ 3.4×18 topics
  15. Poison Control Centers2▲ 200×1 topic
  16. Toxic Exposure Surveillance2▲ 200×1 topic
  17. Alzheimer's Disease2▲ 11×7 topics
  18. Neurological Disorders2▲ 5.4×12 topics
  19. Neuroprotection2▲ 8.0×9 topics
  20. Bipolar Spectrum Disorder2▲ 118×1 topic
  21. Suicide Risk2▲ 88×1 topic
  22. Treatment Guidelines2▲ 13×2 topics
  23. Forensic Toxicology2▲ 99×2 topics
  24. Metabolism2▲ 4.9×16 topics
  25. Designer Drugs2▲ 130×1 topic
  26. Drug Analysis2▲ 130×1 topic
  27. Method Validation2▲ 44×2 topics
  28. Toxicity Assessment2▲ 68×2 topics
  29. Dementia2▲ 24×2 topics
  30. Genetic Variation2▲ 11×3 topics
  31. Mitochondrial Dysfunction1▲ 7.3×9 topics
  32. Substance Use Disorders1▲ 29×2 topics
  33. Cognitive Decline1▲ 16×1 topic
  34. Cognitive Training1▲ 22×2 topics
  35. Ischemic Stroke1▲ 13×3 topics
  36. Mild Cognitive Impairment1▲ 23×1 topic
  37. Mortality Risk1▲ 8.1×4 topics
  38. Pharmacokinetics1▲ 7.4×8 topics
  39. Seizures1▲ 32×2 topics
  40. Stroke1▲ 10×6 topics

Which research topics does Optimisation Thérapeutique en Neuropsychopharmacologie publish most on?

By volume in 2022–2025: Poisoning and overdose treatments, Bipolar Disorder and Treatment, Forensic Toxicology and Drug Analysis and Dementia and Cognitive Impairment Research.

  1. 1 Poisoning and overdose treatments Emergency Medicine 2 works
  2. 2 Bipolar Disorder and Treatment Psychiatry and Mental health 2 works
  3. 3 Forensic Toxicology and Drug Analysis Toxicology 2 works
  4. 4 Dementia and Cognitive Impairment Research Psychiatry and Mental health 1 works
  5. 5 Alzheimer's disease research and treatments Physiology 1 works
  6. 6 Acute Ischemic Stroke Management Epidemiology 1 works
  7. 7 Neurological and metabolic disorders Endocrinology, Diabetes and Metabolism 1 works
  8. 8 Substance Abuse Treatment and Outcomes Epidemiology 1 works
  9. 9 Opioid Use Disorder Treatment Public Health, Environmental and Occupational Health 1 works
  10. 10 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.1%not open51.9%

World: 28% of research is openly available.

with international co-authors32.4%domestic only67.6%

World: 19% is written across borders.

How has Optimisation Thérapeutique en Neuropsychopharmacologie's research output changed?

Output in 2018–2022 was 106% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Paris

All research institutions in Paris

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.